Novo Nordisk stock price forecast: Challenging the $49.51 resistance as NVO advances 3.52%

Traders Union
All News
Financial News
Novo Nordisk jumps 3.52% to $47.4 today

Highlights

NVO/USD maintains strong short- and medium-term bullish momentum, trading above key moving averages and showing notable intraday gains.
Momentum indicators confirm a dominant buyer presence, yet diverging oscillators and overbought signals suggest potential for near-term price consolidation.
Price is projected to remain in a $45.29–$49.51 sideways range over the next 2–3 days unless a break of resistance or support occurs.

Uptrend momentum builds with resistance and overbought signals converging

On the hourly chart, NVO is positioned above its MA-20 at $45.41 and MA-50 at $44.55, but remains below the MA-200 at $48.05, which serves as a key resistance. The Ichimoku Kijun level at $44.97 acts as immediate support. Recent readings show MACD and ADX signaling strong upward momentum. The RSI stands at 74.92, deep in overbought territory, with CCI also leaning toward buying pressure. However, the Stoch RSI displays a strong sell signal, and Bull/Bear Power (BBP) registers as overbought, suggesting some caution as the price approaches the top of its intraday range.

Upside favored as volatility defines trading range

Over the next two to three trading days, NVO is expected to trade within a $45.29 to $49.51 range, reflecting the current volatility band relative to present levels. Probabilities suggest a very high chance of continued price gains and a very low chance of a downward move. The baseline scenario anticipates price consolidation within a sideways band, while a break above $49.51 could trigger a bullish move. A drop below immediate support at $44.97 would open the door to a potential bearish scenario.

Viktoras Karapetjanc, expert at Traders Union, sees Novo Nordisk showing strong short-term momentum as it holds above key moving averages and support at $44.97. He believes technical indicators point to continued upside, even with the stock approaching overbought zones and resistance at $48.05. Macro drivers are quiet, which keeps market sentiment positive and the trend intact. "I remain constructive on NVO, with the price action signaling further gains as long as it holds above near-term support levels."

Previously it was reported that Novo Nordisk’s shares exhibited short- and medium-term bullish momentum, underpinned by positive corporate developments and ongoing investor interest. The current technical setup not only reaffirms this upward bias but also highlights that a decisive move above $49.51 would be a key bullish trigger to monitor in the coming sessions.

Source of Data: NVO Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.